Abstract | OBJECTIVE: METHODS: From 2008 to 2011, forty-seven patients with locally advanced cervical cancer were enrolled in this study. All patients received high-technology (3D CRT/IMRT) whole pelvic radiotherapy with a total dose of 45-46 Gy plus image-guided High-Dose-Rate intracavitary brachytherapy 6.5-7 Gy × 4 fractions to a High-Risk Clinical Target Volume (HR-CTV) according to GEC-ESTRO recommendations. The dose parameters of the HR-CTV for bladder, rectum and sigmoid colon were recorded, as well as toxicity profiles. In addition, the endpoints for local control, disease-free, metastasis-free survival and overall survival were calculated. RESULTS: At the median follow-up time of 26 months, the local control, disease-free survival, and overall survival rates were 97.9%, 85.1%, and 93.6%, respectively. The mean dose of HR-CTV, bladder, rectum and sigmoid were 93.1, 88.2, 69.6, and 72 Gy, respectively. In terms of late toxicity, the incidence of grade 3-4 bladder and rectum morbidity was 2.1% and 2.1%, respectively. CONCLUSIONS: A combination of image-guided brachytherapy and IMRT/3D CRT showed very promising results of local control, disease-free survival, metastasis-free survival and overall survival rates. It also caused a low incidence of grade 3-4 toxicity in treated study patients.
|
Authors | Ekkasit Tharavichitkul, Somvilai Chakrabandhu, Somsak Wanwilairat, Damrongsak Tippanya, Wannapha Nobnop, Nantaka Pukanhaphan, Razvan M Galalae, Imjai Chitapanarux |
Journal | Gynecologic oncology
(Gynecol Oncol)
Vol. 130
Issue 1
Pg. 81-5
(Jul 2013)
ISSN: 1095-6859 [Electronic] United States |
PMID | 23603369
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2013 Elsevier Inc. All rights reserved. |
Chemical References |
- Antineoplastic Agents
- Cisplatin
|
Topics |
- Adult
- Antineoplastic Agents
(adverse effects, therapeutic use)
- Brachytherapy
(adverse effects, methods)
- Chemoradiotherapy
- Cisplatin
(adverse effects, therapeutic use)
- Disease-Free Survival
- Female
- Humans
- Middle Aged
- Radiotherapy, Conformal
(adverse effects, methods)
- Radiotherapy, Image-Guided
(adverse effects, methods)
- Survival Rate
- Treatment Outcome
- Uterine Cervical Neoplasms
(drug therapy, radiotherapy)
|